American Renal Associates (ARA) Tops Q3 EPS by 4c

American Renal Associates (NYSE: ARA) reported Q3 EPS of $0.19, $0.04 better than the analyst estimate of $0.15. Revenue for the quarter came in at $211 million versus the consensus estimate of $217.05 million.

For earnings history and earnings-related data on American Renal Associates (ARA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c